Antipsychotic treatment of schizophrenia: Two steps forward, one step back Rajiv Tandon Invited Commentary 11 July 2007 Pages: 263 - 264
Is prevention of and early intervention for anxiety disorders possible? Dan J. Stein Clinical trials report 11 July 2007 Pages: 269 - 270
Rating scales for anxiety/anxiety disorders Richard Balon OriginalPaper 11 July 2007 Pages: 271 - 277
Glutamate and anxiety disorders Jonathan M. AmielSanjay J. Mathew OriginalPaper 11 July 2007 Pages: 278 - 283
Self-help interventions for anxiety disorders: An overview Pim CuijpersJosien Schuurmans OriginalPaper Open access 11 July 2007 Pages: 284 - 290
Antiepileptic drugs for the treatment of post-traumatic stress disorder Heather A. Berlin OriginalPaper 11 July 2007 Pages: 291 - 300
Trichotillomania, stereotypic movement disorder, and related disorders Dan J. SteinJoseph P. Garnerthe Trichotillomania Learning Center Scientific Advisory Board OriginalPaper 11 July 2007 Pages: 301 - 302
A systematic review of the quality of information on the treatment of anxiety disorders on the internet Jonathan C. IpserSarah DewingDan J. Stein OriginalPaper 11 July 2007 Pages: 303 - 309
Individualizing antipsychotic drug therapy in schizophrenia: The promise of pharmacogenetics Charles U. NnadiAnil K. Malhotra OriginalPaper 11 July 2007 Pages: 313 - 318
Reducing variation in the pharmacologic treatment of schizophrenia: Defining acceptable standards of treatment Robert J. Constantine OriginalPaper 11 July 2007 Pages: 319 - 324
Early intervention in schizophrenia: Current and future perspectives Matcheri S. KeshavanAli Amirsadri OriginalPaper 11 July 2007 Pages: 325 - 328
Dopamine hypothesis of schizophrenia: Making sense of it all Mitsuru TodaAnissa Abi-Dargham OriginalPaper 11 July 2007 Pages: 329 - 336
Schizophrenia: From brain morphology to psychopathology Adriana FosterManzoor UsmanPeter Buckley OriginalPaper 11 July 2007 Pages: 337 - 342